Craft

Advanced
  • Home
  •  / Lycia Therapeutics
Lycia Therapeutics

Lycia Therapeutics

Total Funding

$75.4 M

Lycia Therapeutics Summary

Company Summary

Overview
Lycia Therapeutics is a biotechnology company. It uses the lysosomal targeting chimeras (LYTACs) platform to develop therapeutics that degrade extracellular and membrane-bound proteins.
Type
Private
Status
Active
Founded
2019
HQ
South San Francisco, CA, US | view all locations
Website
https://lyciatx.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Steve Staben

    Steve Staben, Chief Scientific Officer

  • Winsome Chung

    Winsome Chung, Vice President, Finance

    • William J. Rieflin, Chairman

      • Tim Anderson, Director

        LocationsView all

        1 location detected

        • South San Francisco, CA HQ

          United States

          Building 84, 681 Gateway Blvd 3rd floor

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX